Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Cash & Current Investments (2019 - 2025)

Avai Bio's Cash & Current Investments history spans 6 years, with the latest figure at $281.0 for Q1 2024.

  • On a quarterly basis, Cash & Current Investments fell 99.74% to $281.0 in Q1 2024 year-over-year; TTM through Mar 2024 was $281.0, a 99.74% decrease, with the full-year FY2024 number at $281.0, down 99.74% from a year prior.
  • Cash & Current Investments hit $281.0 in Q1 2024 for Avai Bio, down from $896.0 in the prior quarter.
  • Over the last five years, Cash & Current Investments for AVAI hit a ceiling of $107472.0 in Q1 2023 and a floor of $281.0 in Q1 2024.
  • Historically, Cash & Current Investments has averaged $24023.9 across 5 years, with a median of $17619.5 in 2020.
  • Biggest five-year swings in Cash & Current Investments: skyrocketed 26979.41% in 2020 and later crashed 99.74% in 2024.
  • Tracing AVAI's Cash & Current Investments over 5 years: stood at $29514.0 in 2020, then surged by 104.53% to $60364.0 in 2021, then crashed by 68.84% to $18812.0 in 2022, then crashed by 95.24% to $896.0 in 2023, then crashed by 68.64% to $281.0 in 2024.
  • Business Quant data shows Cash & Current Investments for AVAI at $281.0 in Q1 2024, $896.0 in Q4 2023, and $1480.0 in Q3 2023.